Adding recombinant CCL2 and CSF1 proteins reversed the inhibition of macrophage M2 polarization, recruitment and tumor proliferation phenotypes caused by AS‐99 treatment (Figure 6E,F,H; Figure S8D,E, Supporting Information). Here, CCL2 is linked to neoplasm.